Herbal Medicine Cordyceps sinensis Improves Health-Related Quality of Life in Moderate-to-Severe Asthma

Table 4

Asthma onset infrequency, severity, and medication change at baseline and immediately following the intervention period.

	Control group; ()		Treatment group; ()
	Baseline	Postintervention	Baseline	Postintervention
Daytime onset	5 (4, 6)	5.5 (4, 10)	7 (1, 12)	2 (0, 5)^bc	2.589	0.010
Nighttime onset	10 (5, 10)	7 (2, 8)	4 (2, 9)	2 (0, 5)^b	1.831	0.067
Nocturnal awakenings	15 (10, 20)	15 (10, 15)	11 (5, 18.75)	5.5 (3, 13.75)^b	1.355	1.175
Symptom-free days	15 (0, 40)	20 (12, 45)	25.5 (10, 52.5)	47.50 (22.75, 57.25)^bd	4.072	0.000
Rescue-free days	10 (0, 45)	20 (0, 30)	8 (0, 37.5)	32.50 (12.50, 49.00)^bd	4.679	0.000
Average inhaled corticosteroids (ug/d)	500 (500, 750)	550 (500, 800)	500 (500, 687.5)	500 ± (200, 750)^b	1.610	0.108

Data are medium (IQR), and versus baseline. and CS group versus control group.